Clinical Review

Hormone therapy and cognition: What is best for the midlife brain?

Author and Disclosure Information

 

References

CASE Resolved

When approaching Jackie, most importantly, I would normalize her experience and tell her that memory problems are common in the menopausal transition, especially for women with bothersome VMS. Research suggests that the memory problems she is experiencing are related to hormonal changes and not to AD, and that her memory will likely improve once she has transitioned through the menopause. I would tell her that AD is rare at midlife unless there is a family history of early onset of AD (before age 65), and I would verify the age at which her mother was diagnosed to confirm that it was late-onset AD.

For now, I would recommend that she be prescribed HT for her bothersome hot flashes using one of the “safe” formulations in the Table on page 24. I also would tell her that there is much she can do to lower her risk of AD and that it is best to start now as she enters her 50s because that is when AD changes typically start in the brain, and she can start to prevent those changes now.

I would tell her that experts in the field of AD agree that these lifestyle interventions are currently the best way to prevent AD and that the more of them she engages in, the more her brain will benefit. I would advise her to continue to manage her hypertension and to consider ways of lowering her BMI to enhance her brain health. Engaging in regular brisk walking or other aerobic exercise, as well as incorporating more of the Mediterranean diet into her daily food intake would also benefit her brain. As a working woman, she is exercising her brain, and she should consider other cognitively challenging activities to keep her brain in good shape.

I would follow up with her in a few months to see if her memory functioning is better. If it is not, and if her VMS continue to be bothersome, I would increase her dose of HT. Only if her VMS are treated but her memory problems are getting worse would I screen her with a Mini-Mental State Exam and refer her to a neurologist for an evaluation.

Pages

Recommended Reading

What is the association of menopausal HT use and risk of Alzheimer disease?
MDedge ObGyn
Romosozumab gets FDA approval for treating osteoporosis
MDedge ObGyn
Discuss compounded bioidentical hormones and cancer risk
MDedge ObGyn
Online counseling clarifies treatment options for menopausal women
MDedge ObGyn
What to do when a patient presents with breast pain
MDedge ObGyn
2019 Update on menopause
MDedge ObGyn
An app to help women and clinicians manage menopausal symptoms
MDedge ObGyn
CVD risk upped in postmenopausal breast cancer survivors
MDedge ObGyn
Transdermal estradiol may modulate the relationship between sleep, cognition
MDedge ObGyn
Office hysteroscopic evaluation of postmenopausal bleeding
MDedge ObGyn